Correlation Between Alvotech and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alvotech and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Entero Therapeutics,, you can compare the effects of market volatilities on Alvotech and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Entero Therapeutics,.

Diversification Opportunities for Alvotech and Entero Therapeutics,

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Alvotech and Entero is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Alvotech i.e., Alvotech and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Alvotech and Entero Therapeutics,

Given the investment horizon of 90 days Alvotech is expected to generate 0.28 times more return on investment than Entero Therapeutics,. However, Alvotech is 3.63 times less risky than Entero Therapeutics,. It trades about 0.02 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.22 per unit of risk. If you would invest  1,240  in Alvotech on August 23, 2024 and sell it today you would earn a total of  4.00  from holding Alvotech or generate 0.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Alvotech  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Alvotech 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Alvotech is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Entero Therapeutics, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Alvotech and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alvotech and Entero Therapeutics,

The main advantage of trading using opposite Alvotech and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Alvotech and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume